NASDAQ : AHI
$0 (0.0%)
NASDAQ
Scott Montgomery
Software - Application
Technology
AHI
32
AU
USD
1.26
0.06
0.06
0.00
0.00
$368.43K
1340.41
9.09
-104.00
-0.64
-$0.56
-$4.15M
-1125.70%
-1125.70%
-219.41%
-27.28%
-3.85
-0.04
-0.04
0/5
0 Analysts
%
13.90
2/9
-$8.89M
$15.2M
$11.92M
-$14.11M
$495.9M
1345.97
-159.93
0.06
-219.41%
-115.33%
-26.05%
-0.96%
-5202 days
| Name | Title |
|---|---|
| Anita Swan | Marketing Director |
| Riaan Conradie | Chief Science Officer |
| Scott Montgomery | Chief Executive Officer & Executive Director |
| Simon Durack | Chief Financial Officer & Company Secretary |
| Terence Stupple | Chief Technology Officer |
| Vlado Bosanac | Founder & Head of Strategy |
| Nadine Amesz | Head of Operations |
| Katherine Iscoe | Co-Founder & Executive Director |
| Dylan R. Garnett | Chief Innovation Officer |
| Kevin Michael Baum | Chief Product Officer |
No votes yet today — be the first to share your view!
About Advanced Health Intelligence Ltd (NASDAQ:AHI) Stock
Advanced Health Intelligence Ltd is an Australian-based company operating internationally, specializing in the development of mobile applications and advanced technological solutions. A cornerstone of its offerings is BodyScan, a patented, proprietary dimensioning technology. This innovative solution empowers users to accurately measure and assess their body dimensions simply by utilizing a smartphone. Beyond BodyScan, the company also provides FaceScan, designed to ascertain vital signs and evaluate risks associated with cardiovascular diseases, heart attacks, and strokes. Additionally, its portfolio includes DermaScan, a specialized dermatological scanning tool. These technologies cater to a diverse array of sectors, including mobile health and telehealth, the life and health insurance i ... ndustry, fitness and wellness providers, and consumer apparel businesses. Established in 2014 and headquartered in South Perth, Australia, the company has undergone several transformations. It was initially known as MyFiziq Limited before rebranding to Advanced Human Imaging Limited in March 2021, and is now recognized as Advanced Health Intelligence Ltd.
2026-06-06 15:00:00
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demo
Frequently Asked Questions
What is the current Advanced Health Intelligence Ltd (AHI) stock price?
Advanced Health Intelligence Ltd(NASDAQ:AHI) stock price is $1.5 in the last trading session. During the trading session, AHI stock reached the peak price of $1.5 while $1.5 was the lowest point it dropped to. The percentage change in AHI stock occurred in the recent session was 0.0% while the dollar amount for the price change in AHI stock was $0.
AHI's industry and sector of operation?
The NASDAQ listed AHI is part of Software - Application industry that operates in the broader Technology sector.
Who are the executives of AHI?
Anita Swan
| Marketing Director
Riaan Conradie
| Chief Science Officer
Scott Montgomery
| Chief Executive Officer & Executive Director
Simon Durack
| Chief Financial Officer & Company Secretary
Terence Stupple
| Chief Technology Officer
How many employees does AHI have?
Number of AHI employees currently stands at 32. AHI operates from 71-73 The Esplanade, South Perth, WA 6151, AU.
Link for AHI official website?
Official Website of AHI is: https://www.advancedhumanimaging.com
How do I contact AHI?
AHI could be contacted at phone #61 8 6244 0388 and can also be accessed through its website. AHI operates from 71-73 The Esplanade, South Perth, WA 6151, AU.
How many shares of AHI are traded daily?
The average number of AHI shares traded daily for last 3 months was 196.
What is the market cap of AHI currently?
The market value of AHI currently stands at $345.76M with its latest stock price at $1.5